Profile data is unavailable for this security.
About the company
Pharmesis International Ltd. is a Singapore-based investment holding company. The principal activities of the Company and its subsidiaries are development, manufacture, packaging and sale of western medicine, traditional Chinese medicine (TCM), health tonic products, wholesale of drugs, raw products, antibiotics and antibiotic agents. Its pharmaceutical products are sold in the People’s Republic of China (PRC). The Company’s segments include Western drugs, TCM formulated drugs, and Distribution. The Western drugs segment refers mainly to chemically formulated drugs marketed under the Kinna brand. The TCM formulated drugs segment refers to traditional Chinese medicine marketed under the Longlife brand. Distribution segment refers to agency products and internally manufactured products which are marketed through the distribution arm. Its subsidiaries include Chengdu Kinna Pharmaceutical Co., Ltd and Sichuan Longlife Pharmaceutical Co., Ltd.
- Revenue in SGD (TTM)12.37m
- Net income in SGD1.51m
- Incorporated2003
- Employees--
- LocationPharmesis International Ltd5 Kallang Sector #03-02,CHENGDU 349279SingaporeSGP
- Phone+65 68460766
- Fax+65 67740269
- Websitehttps://www.pharmesis.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Onyx Biotec Ltd | 9.25m | 148.89k | 8.97m | -- | 30.50 | 1.18 | 15.54 | 0.9696 | 1.16 | 1.16 | 44.50 | 30.18 | 0.7814 | 3.90 | 2.95 | -- | 1.26 | -- | 1.90 | -- | 29.72 | -- | 1.61 | -- | 1.35 | 2.13 | 0.2233 | -- | 15.26 | -- | 36.31 | -- | -- | -- |
| Rua Bioscience Ltd | 1.15m | -2.63m | 9.04m | 12.00 | -- | 1.64 | -- | 7.85 | -0.0179 | -0.0179 | 0.0076 | 0.0213 | 0.2082 | 2.86 | 4.70 | 125,940.00 | -47.59 | -34.67 | -58.60 | -37.98 | 35.39 | -- | -228.66 | -1,828.56 | 1.03 | -19.66 | 0.1412 | -- | 1,660.58 | -- | 74.81 | -- | -76.72 | -- |
| NUTEX Befektetesi Nyrt | 1.78k | 1.07m | 9.08m | 1.00 | 8.15 | 0.4431 | 8.48 | 5,104.35 | 1.78 | 1.78 | 0.0029 | 32.72 | 0.00008 | -- | 1.57 | -- | 4.95 | 3.34 | 4.96 | 3.34 | 100.00 | -- | 60,198.00 | 34,081.60 | 309.41 | -- | 0.00 | 0.00 | 0.00 | -9.71 | 147.43 | -- | 11.94 | -- |
| Odi Pharma AB (publ) | 1.27m | -667.75k | 9.13m | 1.00 | -- | 220.56 | -- | 7.19 | -0.2851 | -0.2851 | 0.5266 | 0.016 | 1.33 | -- | 5.29 | 8,971,460.00 | -70.09 | -40.68 | -1,151.76 | -60.97 | -29.08 | -- | -52.61 | -95.17 | -- | -8.51 | 0.00 | -- | -85.94 | -- | -944.49 | -- | -- | -- |
| Nuformix PLC | 0.00 | -1.12m | 9.27m | 3.00 | -- | 6.86 | -- | -- | -0.0004 | -0.0004 | 0.00 | 0.0004 | 0.00 | -- | -- | -- | -65.61 | -- | -88.76 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 82.08 | -- | -- | -- |
| cbdMD Inc | 24.22m | -5.52m | 9.29m | 42.00 | -- | 0.8655 | -- | 0.3835 | -3.92 | -3.92 | 4.77 | 0.8104 | 1.83 | 2.83 | 18.96 | -- | -19.44 | -48.27 | -44.42 | -54.99 | 62.37 | 63.95 | -10.63 | -85.60 | 1.20 | -- | 0.00 | -- | -1.50 | -14.45 | 43.21 | -- | -32.56 | -- |
| Pharmesis International Ltd. | 12.37m | 1.51m | 9.51m | -- | 6.66 | 0.8447 | 5.46 | 0.7688 | 0.045 | 0.045 | 0.4141 | 0.3551 | 0.6707 | 2.95 | 3.16 | -- | 7.54 | -0.9205 | 13.30 | -1.52 | 35.70 | 44.71 | 11.25 | -1.65 | 0.7907 | 13.02 | 0.2089 | -- | 48.24 | 12.70 | 266.96 | -- | -28.88 | -- |
| Tissue Repair Ltd | 2.69m | -3.79m | 9.72m | -- | -- | 0.7824 | -- | 3.61 | -0.0701 | -0.0701 | 0.0499 | 0.2301 | 0.1777 | -- | 60.84 | -- | -24.96 | -24.25 | -26.50 | -25.27 | -- | -- | -140.49 | -518.54 | 22.40 | -- | 0.00 | -- | 236.85 | -- | -2.43 | -- | -- | -- |
| Tian'an Pharmaceutical Co Ltd | 13.44m | 3.97m | 10.10m | -- | 0.0445 | 0.0097 | 2.20 | 0.7511 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
